Poly ethylene glycol (PEG)-Related controllable and sustainable antidiabetic drug delivery systems

Eur J Med Chem. 2021 May 5:217:113372. doi: 10.1016/j.ejmech.2021.113372. Epub 2021 Mar 11.

Abstract

Diabetes mellitus is one of the most challenging threats to global public health. To improve the therapy efficacy of antidiabetic drugs, numerous drug delivery systems have been developed. Polyethylene glycol (PEG) is a polymeric family sharing the same skeleton but with different molecular weights which is considered as a promising material for drug delivery. In the delivery of antidiabetic drugs, PEG captures much attention in the designing and preparation of sustainable and controllable release systems due to its unique features including hydrophilicity, biocompatibility and biodegradability. Due to the unique architecture, PEG molecules are also able to shelter delivery systems to decrease their immunogenicity and avoid undesirable enzymolysis. PEG has been applied in plenty of delivery systems such as micelles, vesicles, nanoparticles and hydrogels. In this review, we summarized several commonly used PEG-contained antidiabetic drug delivery systems and emphasized the advantages of stimuli-responsive function in these sustainable and controllable formations.

Keywords: Antidiabetic; Drug delivery system; PEG; Stimulating responsive release; Sustainable release.

Publication types

  • Review

MeSH terms

  • Diabetes Mellitus / drug therapy*
  • Drug Carriers / chemistry
  • Drug Delivery Systems*
  • Humans
  • Hypoglycemic Agents / chemistry
  • Hypoglycemic Agents / therapeutic use*
  • Micelles
  • Molecular Structure
  • Polyethylene Glycols / chemistry*

Substances

  • Drug Carriers
  • Hypoglycemic Agents
  • Micelles
  • Polyethylene Glycols